Stay updated on GEN3014 Safety Trial in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the GEN3014 Safety Trial in Hematologic Malignancies Clinical Trial page.

Latest updates to the GEN3014 Safety Trial in Hematologic Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a prominent operating-status notice and updated the version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference10%
- Check19 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release revision but no evident changes to core content or pricing.SummaryDifference0.2%
- Check26 days agoChange DetectedProject status updated to Terminated with discontinuation of GEN3014 after review; previous completion status removed, indicating halt of development and recruitment/study activity.SummaryDifference4%
- Check33 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element; overall, there are no significant changes to core content or functionality.SummaryDifference0.6%
- Check40 days agoChange DetectedThe page has been updated to reflect a new revision version (v3.0.1) and a new study status date of September 1, 2025, while the previous revision version (v3.0.0) and an earlier date of August 7, 2025, have been removed.SummaryDifference2%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.SummaryDifference34%
Stay in the know with updates to GEN3014 Safety Trial in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEN3014 Safety Trial in Hematologic Malignancies Clinical Trial page.